生命科学资讯

After-hours movers: Zoom, Agilent, Symbotic By Investing.com - Investing.com UK

Best Practices For Analysis Of IVT mRNA Using The Agilent Fragment Analyzer Systems - Bioprocess Online

Earnings Snapshot: Agilent Technologies guides FY26 above estimates after FQ4 double-beat - Seeking Alpha

Top Stock Reports for Alphabet, Roche & RTX - Nasdaq

Agilent stock edges lower post Q4 print By Investing.com - Investing.com South Africa

Agilent Technologies earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com Nigeria

Agilent: Fiscal Q4 Earnings Snapshot - MarketScreener

Agilent (A) Exceeds Revenue Expectations with Strong Q4 Performa - GuruFocus

Agilent Technologies (A) Projects FY26 Revenue to Reach Up to $7 - GuruFocus

Agilent Technologies earnings beat by $0.01, revenue topped estimates - Investing.com

Earnings Flash (A) Agilent Technologies, Inc. Reports Q4 Revenue $1.86B, vs. FactSet Est of $1.83B - MarketScreener

Earnings Flash (A) Agilent Technologies, Inc. Posts Q4 Adjusted EPS $1.59 per Share, vs. FactSet Est of $1.58 - MarketScreener

Agilent Technologies Reports Fourth-Quarter Fiscal Year 2025 Financial Results - TradingView

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Bakersfield.com

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Business Wire

Agilent beats quarterly revenue estimates on strong demand for lab tools - MarketScreener

FDA's Pazdur is said to raise questions about commissioners actions, new voucher

UK-US drug pricing deal could come as early as this week, sources say

#ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins

Roche expands Veeva partnership with AI-enabled CRM adoption By Investing.com - Investing.com Australia